Miha Furlan

5.3k total citations · 1 hit paper
72 papers, 4.0k citations indexed

About

Miha Furlan is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Miha Furlan has authored 72 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 28 papers in Pulmonary and Respiratory Medicine and 18 papers in Genetics. Recurrent topics in Miha Furlan's work include Blood properties and coagulation (27 papers), Platelet Disorders and Treatments (22 papers) and Complement system in diseases (17 papers). Miha Furlan is often cited by papers focused on Blood properties and coagulation (27 papers), Platelet Disorders and Treatments (22 papers) and Complement system in diseases (17 papers). Miha Furlan collaborates with scholars based in Switzerland, United States and Germany. Miha Furlan's co-authors include Bernhard Lämmle, Rodolfo Robles, Max Solenthaler, Eugene A. Beck, Miriam Galbusera, Manuela Krause, B. Brenner, Paul A. Kyrle, U. Mittler and Giuseppe Remuzzi and has published in prestigious journals such as New England Journal of Medicine, Physical review. B, Condensed matter and Blood.

In The Last Decade

Miha Furlan

69 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations Miha Furlan, Rodolfo Robles et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miha Furlan Switzerland	24	2.9k	2.3k	1.4k	1.1k	343	72	4.0k
Spero R. Cataland United States	33	2.7k 0.9×	1.7k 0.7×	1.4k 1.0×	1.0k 0.9×	180 0.5×	113	3.7k
Han‐Mou Tsai United States	32	4.4k 1.5×	3.2k 1.4×	2.1k 1.5×	1.5k 1.4×	235 0.7×	72	5.6k
M. Furlan Switzerland	21	1.2k 0.4×	1.4k 0.6×	454 0.3×	539 0.5×	414 1.2×	85	2.3k
Bruno Rotoli Italy	42	1.2k 0.4×	2.3k 1.0×	323 0.2×	1.1k 1.0×	558 1.6×	185	5.5k
Kasiani C. Myers United States	30	1.4k 0.5×	1.1k 0.5×	458 0.3×	262 0.2×	187 0.5×	149	3.0k
Roshini S. Abraham United States	32	1.7k 0.6×	1.2k 0.5×	439 0.3×	704 0.6×	427 1.2×	126	4.4k
Michael Linenberger United States	24	756 0.3×	1.2k 0.5×	201 0.1×	675 0.6×	295 0.9×	70	3.0k
Joyce Rauch Canada	38	2.7k 0.9×	1.3k 0.6×	401 0.3×	338 0.3×	313 0.9×	122	6.0k
James T. Casper United States	36	1.4k 0.5×	2.0k 0.9×	82 0.1×	487 0.4×	464 1.4×	104	4.3k
Jens Panse Germany	25	917 0.3×	705 0.3×	244 0.2×	407 0.4×	138 0.4×	154	2.2k

Countries citing papers authored by Miha Furlan

Since Specialization

Citations

This map shows the geographic impact of Miha Furlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miha Furlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miha Furlan more than expected).

Fields of papers citing papers by Miha Furlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miha Furlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miha Furlan. The network helps show where Miha Furlan may publish in the future.

Co-authorship network of co-authors of Miha Furlan

This figure shows the co-authorship network connecting the top 25 collaborators of Miha Furlan. A scholar is included among the top collaborators of Miha Furlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miha Furlan. Miha Furlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Christensen, Jeppe Brage, et al.. (2024). Implications of the ICRU 95 quantities for various personal dosimetry techniques. Radiation Measurements. 176. 107207–107207. 2 indexed citations

Cester, D., et al.. (2022). Efficiency evaluation of leaded glasses and visors for eye lens dose reduction during fluoroscopy guided interventional procedures. Physica Medica. 100. 129–134. 2 indexed citations

Furlan, Miha, Eugenie Kirk, & A. Zehnder. (2006). New frequency-modulation readout based on relaxation oscillations. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 559(2). 796–798.

Furlan, Miha. (2004). Proteolytic cleavage of von Willebrand factor by ADAMTS‐13 prevents uninvited clumping of blood platelets. Journal of Thrombosis and Haemostasis. 2(9). 1505–1509. 18 indexed citations

Furlan, Miha. (2002). Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis. Swiss Medical Weekly. 132(1516). 181–189. 7 indexed citations

Merlo, Christoph, Walter A. Wuillemin, Maurice Redondo, et al.. (2002). Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. 161(2). 261–267. 55 indexed citations

Bianchi, Valentina, Rodolfo Robles, Lorenzo Alberio, Miha Furlan, & Bernhard Lämmle. (2002). Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood. 100(2). 710–713. 241 indexed citations

Furlan, Miha, et al.. (2000). Biochemical properties of the fibrinogen component of a fibrin glue before and after severe dry heat treatment. Journal of Biomedical Materials Research. 53(5). 577–583. 3 indexed citations

Furlan, Miha, Rodolfo Robles, Miriam Galbusera, et al.. (1998). von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome. New England Journal of Medicine. 339(22). 1578–1584. 1254 indexed citations breakdown →

10.

Lankhof, H., Marion E. Schiphorst, Martin J. W. IJsseldijk, et al.. (1997). von Willebrand Factor without the A2 Domain Is Resistant to Proteolysis. Thrombosis and Haemostasis. 77(5). 1008–1013. 24 indexed citations

11.

Furlan, Miha, et al.. (1997). Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura. Blood. 89(9). 3097–3103. 417 indexed citations

12.

Beck, Eugene A., et al.. (1996). Fibrinogen Claro — Another dysfunctional fibrinogen variant with γ 275 Arginine → Histidine substitution. Thrombosis Research. 81(1). 145–150. 4 indexed citations

13.

Lüthy, A, et al.. (1990). Inferior vena cava thrombosis in a child with nephroblastoma and combined deficiency of antithrombin III and free protein S. Annals of Hematology. 61(5). 295–297. 3 indexed citations

14.

Furlan, Miha, B.A. Perret, & Eugene A. Beck. (1981). Von Willebrand Activity of Low Molecular Weight Human Factor VIII Increases by Binding to Gold Granules. Thrombosis and Haemostasis. 45(3). 242–246. 10 indexed citations

15.

Furlan, Miha, et al.. (1977). Effects of amidination and chemical cross-linking on human factor VIII (antihemophilic factor). Biochimica et Biophysica Acta (BBA) - Protein Structure. 494(2). 319–325. 4 indexed citations

16.

Furlan, Miha, et al.. (1976). Reactivity of Fibrinogen Crosslinking Sites in the Absence of Thrombin. Thrombosis and Haemostasis. 35(3). 620–627.

17.

Kemp, Graham D., et al.. (1976). Bleeding Disorder with Abnormal Wound Healing, Acid-Soluble Clots and Normal Factor XIII. Thrombosis and Haemostasis. 36(3). 537–541. 13 indexed citations

18.

Bachmann, Peter K., et al.. (1976). Importance of Protease Inhibition in Studies on Purified Factor VIII (Antihaemophilic Factor). Thrombosis and Haemostasis. 35(1). 186–190. 8 indexed citations

19.

Furlan, Miha, et al.. (1968). Purification and properties of a neutral protease from calf thymus nuclei. Biochimica et Biophysica Acta (BBA) - Enzymology. 167(1). 154–160. 50 indexed citations

20.

Furlan, Miha, et al.. (1967). Protein catabolism in thymus nuclei. Biochimica et Biophysica Acta (BBA) - Protein Structure. 147(1). 135–144. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact